Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

The field of dermatology has witnessed remarkable progress in the prevention and treatment of skin diseases over the past ...

This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

External Affairs Minister S. Jaishankar on December 1 warned that the threat of biological weapons and bioterrorism is no longer theoretical. Speaking at a conference on 50 years of the Biological ...

A new study describes a key molecular mechanism that explains how cells exchange information through extracellular vesicles ...

Highlighting 10 innovative late-stage BioPharma drugs with the potential to reshape treatment paradigms and industry dynamics ...

Utilizing the gene-editing technology CRISPR, researchers have found a way to combat chemoresistance in lung cancer cells, restoring hope for patients. Shannon Horning/ SciTech Editor For patients ...

Earlier this year, researchers at CHOP and Penn created a first-of-its-kind drug customized to a unique genetic mutation to save an infant named Baby KJ from dying of a rare liver disorder. KJ Muldoon ...

The FDA has introduced a new “plausible mechanism pathway” aimed at expediting approval of personalized therapies for rare diseases. The approach, detailed in a Nov. 12 article in The New England ...

The plausible mechanism pathway “could accelerate gene therapy/editing development,” analysts at William Blair said Thursday, while adding that additional clarity is needed. Individualized therapies ...

In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory pathway that could trigger a seismic shift in how bespoke gene editing therapies ...